Pixelworks (NASDAQ:PXLW) Downgraded by StockNews.com to “Sell”

StockNews.com lowered shares of Pixelworks (NASDAQ:PXLW) from a hold rating to a sell rating in a research report report published on Friday morning.

A number of other equities analysts also recently commented on PXLW. Craig Hallum reduced their target price on shares of Pixelworks from $4.00 to $3.00 and set a buy rating for the company in a report on Wednesday, May 15th. Needham & Company LLC reduced their target price on shares of Pixelworks from $2.50 to $2.00 and set a buy rating for the company in a report on Thursday. Finally, Roth Mkm dropped their price target on Pixelworks from $3.00 to $2.00 and set a buy rating on the stock in a research note on Wednesday, May 15th.

Pixelworks Trading Down 1.2 %

Shares of NASDAQ:PXLW traded down $0.01 on Friday, hitting $0.84. 311,814 shares of the company’s stock were exchanged, compared to its average volume of 256,184. Pixelworks has a 12 month low of $0.80 and a 12 month high of $3.08. The stock has a market capitalization of $48.53 million, a price-to-earnings ratio of -2.15 and a beta of 1.63. The business’s 50 day simple moving average is $0.97 and its two-hundred day simple moving average is $1.71. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.78 and a quick ratio of 4.51.

Pixelworks (NASDAQ:PXLW) last released its quarterly earnings data on Tuesday, May 14th. The semiconductor company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.01. The firm had revenue of $16.05 million during the quarter, compared to the consensus estimate of $16.00 million. Pixelworks had a negative return on equity of 55.94% and a negative net margin of 33.22%. Analysts anticipate that Pixelworks will post -0.51 EPS for the current fiscal year.

Insider Transactions at Pixelworks

In related news, CEO Todd Debonis sold 24,842 shares of the company’s stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $1.15, for a total value of $28,568.30. Following the sale, the chief executive officer now owns 1,765,223 shares in the company, valued at $2,030,006.45. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 4.70% of the company’s stock.

Institutional Investors Weigh In On Pixelworks

A number of large investors have recently bought and sold shares of PXLW. Acadian Asset Management LLC boosted its position in Pixelworks by 219.0% in the 1st quarter. Acadian Asset Management LLC now owns 734,287 shares of the semiconductor company’s stock worth $1,893,000 after purchasing an additional 504,071 shares in the last quarter. Traynor Capital Management Inc. purchased a new stake in Pixelworks in the 1st quarter worth approximately $39,000. Susquehanna Fundamental Investments LLC purchased a new stake in Pixelworks in the 1st quarter worth approximately $84,000. SG Americas Securities LLC purchased a new stake in Pixelworks in the 1st quarter worth approximately $50,000. Finally, ClariVest Asset Management LLC purchased a new stake in Pixelworks in the 1st quarter worth approximately $530,000. Hedge funds and other institutional investors own 21.37% of the company’s stock.

Pixelworks Company Profile

Pixelworks, Inc, together with its subsidiaries, develops and markets semiconductor and software solutions for mobile, home and enterprise, and cinema markets in the United States, Japan, China, Taiwan, Korea, and Europe. The company offers imageprocessor integrated circuits, such as embedded microprocessors, digital signal processing technology, and software that control the operations and signal processing within high-end display systems; visual processor integrated circuits that works with a mobile application processor; and transcoder integrated circuits which includes software that control the operations and signal processing for converting multiple bitrates, resolutions and codecs to provide bandwidth efficient video transmissions based on industry standard protocols.